Number of Shares
2.01 Mil
Current Holdings Value*
$16.40 Mil
% of Portfolio
0.96%
Total Estimate Gain
$-15.03 Mil
% of Total Estimate Gain
-46.56%

RICE HALL JAMES & ASSOCIATES, LLC's Amicus Therapeutics Inc Holding Summary

As of 2025-03-31, RICE HALL JAMES & ASSOCIATES, LLC held 2.01 Mil shares of Amicus Therapeutics Inc(FOLD), totaling $16.40 Mil. This investment constitutes 0.96% of their stock portfolio, and RICE HALL JAMES & ASSOCIATES, LLC now holds 0.65% of the outstanding Amicus Therapeutics Inc(FOLD) stock.

The initial trade took place in 2020Q4. And since then RICE HALL JAMES & ASSOCIATES, LLC has made 9 purchases of FOLD, at an average price of $12.91, for a total of 2.50 Mil shares. In addition, there have been 9 sales at an average price of $10.77 for 489,284.00 shares. Based on historical transaction data and FOLD's current price of $5.96, RICE HALL JAMES & ASSOCIATES, LLC's estimated gain on his FOLD holdings is $-15.03 Mil, reflecting a -46.56% gain to date.

RICE HALL JAMES & ASSOCIATES, LLC FOLD ($5.96) Holding Chart

RICE HALL JAMES & ASSOCIATES, LLC FOLD ($5.96) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1